SHSE:688273's Forward Dividend Yield % is ranked better than 64.44% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs SHSE:688273: 2.99
During the past 12 months, Nanjing Medlander Medical Technology Co's average Dividends Per Share Growth Rate was -30.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 11.90% per year.
During the past 8 years, the highest 3-Year average Dividends Per Share Growth Rate of Nanjing Medlander Medical Technology Co was 11.90% per year. The lowest was 11.90% per year. And the median was 11.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Nanjing Medlander Medical Technology Co (SHSE:688273) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Nanjing Medlander Medical Technology Co Forward Dividend Yield % Related Terms
SHSE:688273 vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, Nanjing Medlander Medical Technology Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Medlander Medical Technology Co Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Medlander Medical Technology Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Nanjing Medlander Medical Technology Co's Forward Dividend Yield % falls into.
Nanjing Medlander Medical Technology Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Nanjing Medlander Medical Technology Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.500000
2026-05-26
2026-05-25
2026-05-26
Cash Dividend
quarterly
CNY:CNY 1.000000
CNY 0.300000
2025-11-27
2025-11-26
2025-11-27
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.99% mean?
Nanjing Medlander Medical Technology Co (SHSE:688273) has a Forward Dividend Yield % of 2.99% as of Jul. 03, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Nanjing Medlander Medical Technology Co and its competitors. According to the industry distribution chart, Nanjing Medlander Medical Technology Co ranks #112 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 35.6%.
Is Nanjing Medlander Medical Technology Co's Forward Dividend Yield % too high?
Nanjing Medlander Medical Technology Co's current Forward Dividend Yield % is 2.99%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.03. Nanjing Medlander Medical Technology Co's value of 2.99% is 47.3% above this industry median. Based on the distribution chart, Nanjing Medlander Medical Technology Co ranks #112 out of 315 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nanjing Medlander Medical Technology Co has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Medlander Medical Technology Co's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nanjing Medlander Medical Technology Co ranks #112 out of 315 companies for Forward Dividend Yield %. This puts Nanjing Medlander Medical Technology Co in the upper half of its industry. The industry median Forward Dividend Yield % is 2.03. Nanjing Medlander Medical Technology Co's value of 2.99% is 47.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.03, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Medlander Medical Technology Co's current Forward Dividend Yield % of 2.99% is 47.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Nanjing Medlander Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Medlander Medical Technology Co's current Forward Dividend Yield % is 2.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Medlander Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co (SHSE:688273) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥34.81, compared to a current price of ¥41.18 — trading 18.3% above its estimated fair value. The current Forward Dividend Yield % is 2.99% and 47.3% above the Medical Devices & Instruments industry median of 2.03. Nanjing Medlander Medical Technology Co's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Nanjing Medlander Medical Technology Co (SHSE:688273), the current Forward Dividend Yield % is 2.99% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Medlander Medical Technology Co (SHSE:688273) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co stock appears to be overvalued.
The current stock price of ¥41.18 is trading 18.3% above its estimated GF Value™ of ¥34.81.
GuruFocus considers Nanjing Medlander Medical Technology Co to be Modestly Overvalued.
Key valuation signals for SHSE:688273:
Forward Dividend Yield %: 2.99%
GF Value™: ¥34.81 vs. price of ¥41.18 (18.3% above fair value)
Industry Position: 47.3% above the Medical Devices & Instruments median (#112 of 315)
No single metric tells the full story. See the SHSE:688273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Medlander Medical Technology Co Business Description
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
81GF Score
Get the complete analysis for SHSE:688273
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688273 has been successfully added to your 